Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Traumatic Encephalopathy

University of Texas Southwestern Medical CenterSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Traumatic Encephalopathy cohort.

Asset / SponsorPhaseRating
FLORTAUCIPIR
Molecular NeuroImaging
Phase 1CC
GOSURANEMAB
University of California, San Francisco
Phase 1CC
FDDNP
University of California, Los Angeles
D
Intranasal Auto-M2-Bfs
Russian Academy of Medical Sciences
Phase 1/2NR

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →